|
Cell Death and Survival
|
apoptosis of lung cancer cell lines
|
5.80E-06
|
↓
|
CAMP, EREG, G0S2, HSPA5, MCL1, RASD1, SERPINF1, TNFSF10
|
|
apoptosis of tumor cell lines
|
2.08E-05
|
↓
|
AR, BCL2A1, CAMP, CAV1, COL18A1, CREM, CTSD, EREG, G0S2, HSPA5, IL18, MAOA, MCL1, NFKBIA, NR0B2, PLAU, RASD1, SERPINF1, TNFSF10, UCHL1
|
|
cell death of lung cancer cell lines
|
3.21E-06
|
↓
|
CAMP, EREG, G0S2, HSPA5, MCL1, NFKBIA, RASD1, SERPINF1, TNFSF10
|
|
cell death of tumor cell lines
|
2.75E-05
|
↓
|
AR, BCL2A1, BTG1, CAMP, CAV1, COL18A1, CREM, CTSD, EREG, FETUB, G0S2, HSPA5, IL18, MAOA, MCL1, NFKBIA, NR0B2, PLAU, PPAT, RASD1, SERP
|
|
cellular degradation
|
3.77E-04
|
↓
|
AR, CACNA1D, CAV1, CREM, CTSD, LYZ, UCHL1
|
|
Cellular Assembly and Organization
|
formation of filaments
|
1.36E-03
|
↑
|
AR, CAV1, COL18A1, HSPA5, PTGDS, SERPINF1, TTR, TUBB
|
|
Organismal Development
|
development of body axis
|
1.99E-04
|
↑
|
ANGPTL3, CCKAR, COL18A1, CREM, CTSD, DIO3, GPR34, HHEX, HSP90B1, INSIG1, LUM, MAOA, NFKBIA, PLAU, SERPINF1
|
|
Immune Cell Trafficking
|
activation of antigen presenting cells
|
3.47E-04
|
↓
|
CAMP, GJB1, HNF4A, HSP90B1, IL18, LECT2, SERPINF1, TNFSF10
|
|
Renal and Urological System Development
|
cell viability of kidney cell lines
|
3.05E-04
|
↓
|
CAV1, HSP90B1, HYOU1, NFKBIA
|
|
Cardiovascular Disease
|
vascular lesion
|
2.94E-07
|
↑
|
ACAT2, CACNA1D, COL18A1, IL18, LPL, MGP, mir-221, NFKBIA, PLAU, TNFSF10
|
